Abstract submission is open online until June 1st, 2020 (Monday) at apots2020.com
Abstracts must be written in English.
Abstracts must be submitted via the online abstract submission system. Submissions by post, email, fax or any other means will NOT be accepted.
The FIRST AUTHOR will be the PRESENTING author. The first (presenting) author is expected to register and pay the full registration fee, attend the Congress and make the presentation.
Author must provide an accurate email address during the submission process. Abstract submission results and abstract-related correspondence will be sent by email to the submitting author.
Abstract begins with title, author(s), and institution(s)
Abstract TITLE must be concise without any abbreviations. Define each abbreviation the first time it is used in the abstract by placing what it stands for in parentheses.
Abstract content MUST NOT EXCEED 250 WORDS and should include the following headings: PURPOSE, METHODS, RESULTS and CONCLUSIONS. Do not include graphs, tables, images or references in the abstract.
Do not mention in the abstract the names of any affiliated institutes, academic institutions, hospitals, eye centres, etc. or names of any individuals involved in the study. Otherwise, the abstract will be rejected outright.
During submission process, authors can choose between POSTER PRESENTATION and FREE PAPER PRESENTATION for each submitted.
The Selection Committee strongly recommends that authors submit their abstracts as early as possible in order to avoid a last-minute rush and system congestion. When the abstract is submitted, it can still be revised until June 1st, 2020 (Monday). Kindly note that only the latest version will be reviewed.
Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all future correspondence. If you do not receive an acknowledgement within 24 hours after submission, please contact the Congress Secretariat by email at email@example.com.
Submitted abstracts will be peer-reviewed by the Selection Committee. The review process is confidential and the decision is final.
Authors will be notified of the abstract selection results no later than July 1st, 2020 (Wednesday) and may be given the option to change the format of their presentation as a condition for acceptance.